5-B8 monoclonal antibody (Medared/H Lundbeck)

N/A

Report date: 2025/01/26 18:50:25

Base Information

Drug Name5-B8 monoclonal antibody (Medared/H Lundbeck)
Drug Alias Name5-B8 monoclonal antibody (Gladstone/UC San Diego/UC San Fransisco/Lundbeck)Immunotherapy (Medared/Gladstone/UC San Diego/UC San Fransisco/Lundbeck)5-B8 monoclonal antibody (Therini Bio/H Lundbeck)Immunotherapy (Therini Bio/Gladstone/UC San Diego/UC San Fransisco/Lundbeck)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionFibrinogen inhibitors
TargetsFibrinogen
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTherini Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesTherini Bio IncH. Lundbeck A/S
Inactive CompaniesUniversity Of California San FranciscoGladstone Institute of Neurological DiseaseUniversity Of California San Diego
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A